<DOC>
	<DOCNO>NCT02167165</DOCNO>
	<brief_summary>This study test hypothesis response digoxin modulate single Nucleotid Polymorphism ( SNP ) : - Multi Drug Resistance ( MDR1 ) gene haplotype Solute carrier organic anion transporter family member 1B3 ( SLCO1B3 ) gene Polymorphism role response treatement . - Aldosterone synthase ( CYP11B2 ) gene sodium channel , voltage-gated , type V alpha subunit gene ( SCN5A ) correlate atrial fibrillation role response digoxin .</brief_summary>
	<brief_title>Role SNP DIGOXIN Response Atrial Fibrillation Patients</brief_title>
	<detailed_description>The frequency distribution single nucleotide polymorphism ( SNPs ) haplotypes ABCB1 SLCO1B3 gene varies largely among population . The aim study investigate genomic variation influence two gene response digoxin Tunisian atrial fibrillation ( AF ) patient . In fact human P-glycoprotein ( P-gp ) encode ABCB1 gene ( MDR1 ) , locate chromosomal region 7q21 consist 28 exon . To date , 50 SNPs report gene , know functional relevance also alter pharmacokinetics substrate drug . The aim current study analyze ABCB1 : C1236T ( Gly412Gly ) , G2677 &gt; T⁄A ( Ala893Ser/ Thr ) C3435T ( Il1145Ile ) polymorphism . SLCO1B3 ( OATP1B3 ) gene locate chromosomal region 12p12 highly polymorphic . It known transport digoxin express sinusoidal membrane hepatocytes human . It mediate uptake hepatocytes may important step elimination digoxin . In study also investigate relationship two deletion polymorphism ( －28 －11 deletion ) ( from－7 －4 deletion ) , T334G ( Ser112Ala ) G699A ( Met233Ile ) SNPs SLCO1B3gene role response digoxin . Another way , progress understand molecular mechanism AF support idea variability response drug therapy may reflect difference disease mechanism , entirely possible response AF highly heterogeneous arrhythmia single pathophysiologic entity . Aldosterone synthase ( CYP11B2 ) gene polymorphism find correlate atrial fibrillation ( AF ) risk . Moreover , human cardiac sodium channel SCN5A responsible fast depolarization upstroke cardiac action potential serf molecular target antiarrhythmic drug . Mutations human cardiac sodium channel gene previously discover spectrum cardiac rhythm disorder . We hypothesize T-344C H558R ( His558Arg ) SNPs CYP11B2 SCN5A gene associate susceptibility AF could implicate variation response Digoxin .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>Patients older 20 year Quick AF ( heart rate &gt; 120 bpm ) diagnose ECG HR 120 bpm Hemodynamically unstable patient AtrioVentricularblock ( second third degree ) Ventricular rhythm disorder Acute coronary syndrome kidney failure Hypokalimia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Digoxin</keyword>
	<keyword>SNP</keyword>
</DOC>